A clinical trial was stopped early after researchers found that a bone marrow cancer drug, is safe and effective for treating ...

In a medical breakthrough, scientists were able to kill 99 per cent of bone cancer cells without causing any harm to the ...

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West ...

When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and ...

Scientists at Aston University have developed bioactive glasses combined with toxic gallium to treat bone cancer with a 99% ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient ...

After 10 days, cancer cells exposed to media conditioned with 10 mg/mL of 4 and 5% gallium-doped glass showed decreased cell ...

Researchers have developed a potential breakthrough treatment for osteosarcoma, the most common form of bone cancer. Learn ...

Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able ...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in ...

Ewing sarcoma is a rare type of cancer that primarily affects bones or soft tissues in children and young adults. Symptoms ...